|
|
Volumn 289, Issue 21, 2003, Pages 2779-2783
|
|
A Host of Novel Agents for Treating Psoriasis, Psoriatic Arthritis Stir Interest
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ADALIMUMAB;
ALEFACEPT;
CALCIPOTRIOL;
CORTICOSTEROID;
CYCLOSPORIN;
EFALIZUMAB;
ETANERCEPT;
ETRETIN;
INFLIXIMAB;
METHOTREXATE;
PSORALEN DERIVATIVE;
RETINOID;
TACROLIMUS;
TAZAROTENE;
BIOLOGICAL RESPONSE MODIFIER;
DERMATOLOGICAL AGENT;
HYBRID PROTEIN;
IMMUNOLOGICAL ADJUVANT;
MONOCLONAL ANTIBODY;
CLINICAL TRIAL;
DISEASE SEVERITY;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
HYPERTENSION;
INJECTION SITE;
LIVER TOXICITY;
MAJOR CLINICAL STUDY;
NEPHROTOXICITY;
PRIORITY JOURNAL;
PSORIASIS;
PSORIATIC ARTHRITIS;
PUVA;
REVIEW;
SKIN MANIFESTATION;
TERATOGENICITY;
ARTICLE;
ADJUVANTS, IMMUNOLOGIC;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, PSORIATIC;
BIOLOGICAL RESPONSE MODIFIERS;
DERMATOLOGIC AGENTS;
HUMANS;
PSORIASIS;
RECOMBINANT FUSION PROTEINS;
|
|
EID: 0037976822
PISSN: 00987484
EISSN: None
Source Type: Journal
DOI: 10.1001/jama.289.21.2779 Document Type: Review |
|
Times cited : (9)
|
|
References (0)
|